Arcutis Biotherapeutics (ARQT) Competitor Comparison
We are evaluating the key criteria listed to compare Arcutis Biotherapeutics (ARQT) against its competitors in the Biotechnology industry.
Market Capitalization
126 / 368Gross Profits
112 / 278Total Revenue
123 / 300EBITDA
296 / 337Free Cashflow
320 / 352Quick Ratio
163 / 357Earnings per Share
183 / 359Dividend yield
0 / 6Total Cash
141 / 358Performance 3 years
142 / 368Performance 5 years
180 / 368Performance 10 years
152 / 368Linearity 3 years
61 / 368Linearity 5 years
120 / 368Linearity 10 years
102 / 368Total Rank
157 / 368Dividend Rank
359 / 368Valuation Rank
85 / 368Piotroski Rank
187 / 368Muliplier Rank
48 / 368Total Cash - ARQT ranking 141 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.